VIVEK SUBBIAH to Risk Factors
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Risk Factors.
Connection Strength
0.133
-
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget. 2016 Sep 27; 7(39):64421-64430.
Score: 0.043
-
Modifiers of risk for infectious complications of cancer therapy in children: the long road ahead. Pediatr Blood Cancer. 2007 Jul; 49(1):3-5.
Score: 0.023
-
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
Score: 0.017
-
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. J Immunother Cancer. 2021 04; 9(4).
Score: 0.015
-
Current update on gallbladder carcinoma. Abdom Radiol (NY). 2021 06; 46(6):2474-2489.
Score: 0.015
-
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
Score: 0.012
-
Incidence and impact of adverse effects of medical care on complications in patients who underwent excision of cervical lymph nodes. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Sep; 118(3):271-7.
Score: 0.009